These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34516306)

  • 1. Two Patients With Severe COVID Pneumonia Treated With the Seraph-100 Microbind Affinity Blood Filter.
    Kelly MM; Wilkinson JD; Rastegar M; Lewis MS; Betancourt J
    J Intensive Care Med; 2021 Oct; 36(10):1228-1232. PubMed ID: 34516306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interim analysis of the COSA (COVID-19 patients treated with the Seraph® 100 Microbind® Affinity filter) registry.
    Schmidt JJ; Borchina DN; Van't Klooster M; Bulhan-Soki K; Okioma R; Herbst L; Rodríguez DS; Premužić V; Büttner S; Bader B; Serednicki W; Zasada E; Schmitz M; Quabach RA; Hrincheva M; Fühner T; Kielstein JT
    Nephrol Dial Transplant; 2022 Mar; 37(4):673-680. PubMed ID: 34875087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of a Critically Ill COVID-19 Patient with the Seraph 100 Microbind Affinity Filter.
    Pape A; Kielstein JT; Krüger T; Fühner T; Brunkhorst R
    TH Open; 2021 Apr; 5(2):e134-e138. PubMed ID: 33870077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seraph-100 Hemoperfusion in SARS-CoV-2-Infected Patients Early in Critical Illness: A Case Series.
    Rifkin BS; Stewart IJ
    Blood Purif; 2022; 51(4):317-320. PubMed ID: 34261058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Center Experience With the Seraph-100® Microbind® Affinity Blood Filter in Patients With SARS-CoV-2 Infection and Septic Shock at a Military Treatment Facility.
    Stoffel S; Boster J; Jarrett Z; Rosas M; Kalra A; Nugyen M; Morris M; Walter R
    Mil Med; 2023 Jul; 188(7-8):e2670-e2674. PubMed ID: 36852879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multicenter Evaluation of the Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19.
    Chitty SA; Mobbs S; Rifkin BS; Stogner SW; Lewis MS; Betancourt J; DellaVolpe J; Abouzahr F; Wilhelm AM; Szerlip HM; Parikh A; Gaeta RM; Rivera I; Park C; Levi B; Anesi GL; Alcover KC; Arnold TB; Howard JT; Sharma K; Pratt KP; Stewart IJ; Chung KK
    Crit Care Explor; 2022 Apr; 4(4):e0662. PubMed ID: 35506015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a biomimetic pathogen adsorbing device on inflammatory biomarkers in COVID-19 patients.
    Schmieszek J; Fuehner T; Renger I; Welte T; Menne J; Fuge J; Van't Klooster MP; Paul A; Siegert A; Borchina DN; Falk CS; Kielstein JT
    Ther Apher Dial; 2024 Oct; 28(5):802-809. PubMed ID: 38736311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-Time Use of the Seraph
    Merrill KA; Krallman KA; Loeb D; Standage SW; Mattoon D; Shan D; Goldstein SL; Schuh MP
    Case Rep Nephrol Dial; 2023; 13(1):1-6. PubMed ID: 36741548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment for Severe Coronavirus Disease 2019 With the Seraph-100 Microbind Affinity Blood Filter.
    Olson SW; Oliver JD; Collen J; Bunin J; Gleeson TD; Foster BE; Simmons MP; Chen HW; Ficke JB; Brown TE; Nau MT; Cebula BR; Kielstein J; Chung KK
    Crit Care Explor; 2020 Aug; 2(8):e0180. PubMed ID: 32766569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of chloroquine and hydroxychloroquine by the Seraph® 100 Microbinda Affinity Blood Filter -a device approved for the treatment of COVID-19 patients.
    Seffer MT; Martens-Lobenhoffer J; Schmidt JJ; Eden G; Bode-Böger SM; Kielstein JT
    Ther Apher Dial; 2021 Apr; 25(2):237-241. PubMed ID: 32558210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Seraph 100
    Conner TL; Vir P; Laing ED; Stewart IJ; Mitre E; Pratt KP
    Antibodies (Basel); 2024 Aug; 13(3):. PubMed ID: 39189236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using the Seraph® 100 Microbind® Affinity blood filter under slow flow conditions through 18 G and 16 G central lines.
    Seffer MT; Meyer TM; Borchina DN; Kielstein JT; Schmidt JJ
    J Vasc Access; 2024 Feb; ():11297298241234073. PubMed ID: 38415617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoperfusion with Seraph 100 Microbind Affinity Blood Filter Unlikely to Require Increased Antibiotic Dosing: A Simulations Study Using a Pharmacokinetic/Pharmacodynamic Approach.
    Selig DJ; Reed T; Chung KK; Kress AT; Stewart IJ; DeLuca JP
    Blood Purif; 2023; 52(1):25-31. PubMed ID: 35526522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of Extracorporeal Blood Purification Techniques for the Treatment of Critically Ill Coronavirus Disease 2019 Patients.
    Niazi NS; Nassar TI; Stewart IJ; Honore PM; Sharma K; Chung KK
    ASAIO J; 2022 Oct; 68(10):1219-1227. PubMed ID: 35417433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemoperfusion in COVID-19.
    Lertussavavivat T; Srisawat N
    Contrib Nephrol; 2023; 200():192-200. PubMed ID: 37263252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin 2.0: A New Approach to the Infection Crisis.
    Seffer MT; Cottam D; Forni LG; Kielstein JT
    Blood Purif; 2021; 50(1):28-34. PubMed ID: 32615569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extracorporeal removal of pathogens using a biomimetic adsorber-A new treatment strategy for the intensive care unit : Seraph® 100 Microbind® Affinity Blood Filter and its fields of application].
    Seffer MT; Kielstein JT
    Med Klin Intensivmed Notfmed; 2024 Jul; ():. PubMed ID: 38981926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the extracorporeal membrane oxygenation inter-hospital transport during coronavirus disease 2019 epidemic: based on the transport experience of 6 cases of severe H1N1 influenza virus pneumonia on extracorporeal membrane oxygenation].
    Xu Q; Jiang X; Wang T; Zhou Q; Wang J; Zhang P; Yang S; Yan H; Tao X; Lu W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):430-434. PubMed ID: 32527347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of the Seraph® 100 Microbind® Affinity Blood Filter to remove bacteria from the blood stream: results of the first in human study.
    Eden G; Schmidt JJ; Büttner S; Kümpers P; Hafer C; Rovas A; Koch BF; Schmidt BMW; Kielstein JT
    Crit Care; 2022 Jun; 26(1):181. PubMed ID: 35715801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.